[ DEBRA Foundation research funding on Epidermolysis bullosa | Research funding ]
Event details
| Date | 11.03.2019 |
| Category | Call for proposal |
Based in Vienna, DEBRA International is a worldwide network of national groups working on behalf of those affected by the genetic skin blistering condition Epidermolysis Bullosa (EB).
The foundation supports projects from basic to advanced preclinical research in the following research areas:
- biology and genetics of all forms of EB.
- development of therapies (including possible gene-therapies, cell-therapies, drug therapies or protein therapies).
- skin cancer in EB.
- clinical-care research to improve the management of EB through symptom relief.
Funding & Duration: max. EUR 270’0000 for up to 36 months (renewable for 1 year only)
- Eligible costs: personnel, research-related costs, open-access publications.
- Does not cover: the PI’s salary, overheads, administrative costs, conference, meetings.
Deadline: 11 March 2019 at 17:00 GMT (annual call)
Application: via the online application portal
Review: June 2019 by the Medical and Scientific Advisory Panel (MSAP) and external reviewers
Decision: July 2019 by the Board of Trustees.
For further information, please have a look at the call webpage, the terms and conditions and funded research projects.
Practical information
- General public
- Free